{"disease":{"id":"myelin-oligodendrocyte-glycoprotein-mog-antibody-related-disorders","name":"myelin oligodendrocyte glycoprotein mog antibody related disorders"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03900221","title":"French Registry for Monitoring Pregnancies for Multiple Sclerosis","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT06617962","title":"Evaluation of Two Cell-based Assays for Diagnosing MOG-IgG Associated Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":240,"lead_sponsor_name":"Huashan Hospital","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}